대한방사성의약품학회지 (Journal of Radiopharmaceuticals and Molecular Probes)

  • 제7권1호
  • /
  • Pages.11-21
  • /
  • 2021
  • /
  • 2384-1583(pISSN)
  • /
  • 2508-3848(eISSN)
대한방사성의약품학회 (Korean Society of Radiopharmaceuticals and Molecular Probes)
권호 표지
DOI QR코드

DOI QR Code

Technology development and market trend analysis of radiopharmaceuticals using patent statistics data

  • Seungil Park (Division of Applied RI, Korea Institute of Radiological and Medical Sciences) ;
  • Heejin Kim (Division of Applied RI, Korea Institute of Radiological and Medical Sciences) ;
  • Jung Young Kim (Division of Applied RI, Korea Institute of Radiological and Medical Sciences)
  • 투고 : 2021.06.09
  • 심사 : 2021.06.28
  • 발행 : 2021.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Radiopharmaceuticals are constantly being studied in the field of tumor diagnosis and therapy. As a result, many patents have been registered related to the development of radiopharmaceutical therapy. In this study, effective patents related to radiology and nuclear medicine filed during the past 10 years were collected from various countries like Korea, United States, Japan, Europe etc., and the application trends and growth stages were analyzed through statistical analysis. From the analysis results of 47,991 patents related to radiology and nuclear medicine, only 6,268 registered patents were found valid, and 80% of those were related to radiopharmaceutical development. In addition, we analyzed the patent of major competitors and used them to analyze the trends in radioisotopes and medicinal research. Among these, all the top 10 major applicants have found to be concentrating on radiopharmaceutical development.

키워드

과제정보

본 연구는 과학기술정보통신부 재원으로 한국원자력의 학원 연구운영비지원사업 (No. 50432-2020)과 한국연구재단의 방사성동위원소 산업 육성 및 고도화 기술지원사업(NRF-2021M2E7A2079369)의 지원을 받아 수행하였음.

참고문헌

  1. H. H. Coenen and J. Ermert 18F-Labelling innovations and their potential for clinical application Clinical and Translational Imaging Syst. Rev. 2018; 6. 3: 169-193 https://doi.org/10.1007/s40336-018-0280-0
  2. S. S. Gambhir Molecular imaging of cancer with positron emission tomography Nat. Rev. Cancer 2002 Sep;2(9):683-93 https://doi.org/10.1038/nrc882
  3. M. T. Ercan and M. Caglar Therapeutic radiopharmaceuticals Curr. Pharm. Des 2000 Jul;6(11):1085
  4. Namhun Lee and Jae Yong Choi Current research status for imaging neuroinflammation by PET J Radiopharm Mol Probes 2020;6(2):58-72
  5. W. A. Volkert and T. J. Hoff man Therapeutic radiopharmaceuticals Chem. Rev. 1999 8; 99(9): 2269-92 https://doi.org/10.1021/cr9804386
  6. J. M. Kelly, S. Ponnala, A. Amor-Coarasa, N. A. Zia, A. Nikolopoulou, C. Williams Jr., D. J. Schlyer, S. G. DiMagno, P. S. Donnelly, and J. W. Babich Preclinical Evaluation of a High-Affinity Sarcophagine-Containing PSMA Ligand for 64Cu/67Cu-Based Theranostics in Prostate Cancer Mol. Pharm. 2020; 17; 6: 1954-1962 https://doi.org/10.1021/acs.molpharmaceut.0c00060
  7. C.van Beers and F. Zand R&D Cooperation, Partner Diversity, and Innovation Performance: An Empirical Analysis J. Prod. Innov. Manag. 2014; 31(2): 292-312 https://doi.org/10.1111/jpim.12096
  8. R.J.W. Tijssen Global and domestic utilization of industrial relevant science: patent citation analysis of science-technology interactions and knowledge flows Res. Policy 2001; 31(1): 35-54 https://doi.org/10.1016/S0048-7333(99)00080-3
  9. X.Wang, S. Zhang, Y. Liu, J. Du and H. Huang How pharmaceutical innovation evolves: The path from science to technological development to marketable drugs Technol. Forecast. Soc. Chang 2021; 167:120698
  10. 특허 분석 보고서「방사선의학 융복합 클러스터 기반기술」 2020.